Forus Raises $160M Series C at $1B Valuation

Forus, a New York-based artificial intelligence company, has raised $160 million in a Series C funding round. The company, which specializes in automating the prescription management process for healthcare providers, has reached unicorn status with this investment, achieving a valuation of $1 billion.

Investors

The funding round was backed by Thrive, General Catalyst, and Accel. These investors join the company as it scales its operations to meet growing demand in the healthcare sector.

Forus Use of Funds

Forus intends to use the capital to scale its operations and further enhance its AI-powered software platform. The company aims to leverage the funding to support its growth projections, which estimate over $50 million in revenue for 2026, and to expand its service offerings that provide real-time medication history checks for healthcare providers.

About Forus

Forus is a New York-based software startup focused on the healthcare industry. Their mission is to improve clinical workflows by automating the prescription process, offering free software that integrates with existing systems to perform real-time medication history checks, thereby reducing administrative burdens for medical professionals.

Funding Details

Company Website: https://forus.com

Company: Forus
Raised: $160M
Round: Series C
Funding Date: May 18, 2026
Additional Investors: Thrive, General Catalyst, Accel
Software Category: Healthcare AI
Source: https://www.techbuzz.ai/newsletters/signalpulse-c116-post-fe6fbc81-3b42-4580-a3ad-f2a125862d01